TABLE 1.

Clinical profiles of chronically SIVmac251-infected, SHIV 89.6P-infected, and vaccinated Mamu-A*01⁺ rhesus monkeys

Monkey	Virus or vaccine	No. of CD4+ T lympho- cytes (μl)	Plasma viral load (RNA copies/ml)	Duration of infection (days)
138-88	SIVmac251	135	<500	2,860
93-98	SIVmac251	695	<500	850
191-96	SIVmac251	450	<500	1,275
94-98	SIVmac251	206	<4,091	850
154-97	SIVmac251	244	1,368	1,550
403-91	SIVmac251(J5)	479	<500	3,315
448-98	SIVmac251	590	<500	NAc
253-96	SIVmac251	637	839	1,315
88-98	SIVmac251	84	1,030,655	1,215
H547	SHIV 89.6P	213	55,023	580
H544	SHIV 89.6P	804	<500	580
AW2P	DNA/rAd5a	1,328
AW28	DNA/rAd5	2,401
90-98	DNA/rMVAb	1,190
95-98	DNA/rMVA	1,114
128-97	DNA/rMVA	1,889
135-97	DNA/rMVA	1,349

^aImmunized with plasmid DNA containing the SIVmac239 gag-pol-nef and HIV-1 89.6P env gene and boosted with recombinant adenovirus serotype 5 constructs expressing the SIV gag-pol-nef and HIV-1 89.6P env genes.

^bImmunized with plasmid DNAs containing the SIVmac239 gag, pol, and nef and the HIV-1 89.6 env epitope genes and boosted with recombinant MVA vectors expressing SIV gag-pol and HIV-1 89.6 env.

^cNA, data not available.